Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ibon Redondo-Angulo"'
Autor:
Esmeralda A. Lewis, Rocío Muñiz-Anquela, Ibon Redondo-Angulo, Leticia González-Cintado, Verónica Labrador-Cantarero, Jacob F. Bentzon
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 43:637-649
Background: To cause atherosclerosis, LDLs (low-density lipoproteins) must first pass through the endothelium and then become retained in the arterial matrix. Which of these two processes is rate-limiting and predicts the topography of plaque formati
Autor:
Ibon Redondo-Angulo, Catalina Núñez-Roa, Mónica Ballesteros, Joan Vendrell, Sonia Fernández-Veledo, Francesc Villarroya, Kelly Roche, Anna Planavila, Miriam Ejarque, Cristina Gutierrez, Rocio Vila-Bedmar, Ana Megia, Bruno Martinez-Perez
Publikováno v:
Translational Research
DOI: 10.1016/j.trsl.2016.06.012 URL: http://www.sciencedirect.com/science/article/pii/S1931524416301050 Filiació URV: SI Inclòs a la memòria: SI Angiopoietin-like protein 8 (ANGPTL8), a protein implicated in lipid and glucose homeostasis, is prese
Autor:
Marta Sitges, Marta Giralt, Anna Planavila, Ibon Redondo-Angulo, Francesc Villarroya, Aleksandra Mas-Stachurska
Publikováno v:
International Journal of Cardiology. 202:819-828
Aim Pregnancy is a physiological model of adaptive and reversible heart enlargement, but the molecular mechanisms determining this kind of physiologic cardiac hypertrophy are poorly known. Here, we analyzed the role of the transcription factor C/EBP
Autor:
Ibon Redondo-Angulo, Marta Giralt, Roser Iglesias, Anna Planavila, Joan Villarroya, Francesc Villarroya
Publikováno v:
The Journal of Nutritional Biochemistry. 26:1328-1337
High-fat diet leads to development of cardiac dysfunction through molecular mechanisms poorly known. The aim of this study is to elucidate the early events in cardiac dysfunction caused by a high-fat diet, before massive alterations due to obesity an
Autor:
Ibon Redondo-Angulo, Celia Rupérez, Anna Planavila, Glòria Garrabou, Francesc Villarroya, Mariona Guitart-Mampel, Gemma Ferrer-Curriu, Aleksandra Mas-Stachurska, Marta Sitges, Joaquim Fernández-Solà
Publikováno v:
The Journal of pathology. 248(1)
FGF21 is an endocrine factor that contributes to multiple pathophysiological processes, mainly via its action as a metabolic regulator and cardioprotective agent. Recent studies have shown increased circulating FGF21 levels in hypertensive patients a
Autor:
Ibon Redondo-Angulo, Francesc Villarroya, Anna Planavila, Francesc Ribas, Jordi Casademont, Marta Giralt, Glòria Garrabou
Publikováno v:
CARDIOVASC RES
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
CARDIOVASCULAR RESEARCH
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
CARDIOVASCULAR RESEARCH
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Aims Oxidative stress mediated by reactive oxygen species (ROS) plays a striking role in the pathogenesis of heart failure, and antioxidants have been shown to attenuate cardiac remodelling in experimental models of cardiac damage. We recently showed
Autor:
Francesc Villarroya, Francisco José Tinahones, Marta Sitges, Ibon Redondo-Angulo, Marta Giralt, Aleksandra Mas-Stachurska, Anna Planavila
Publikováno v:
Cardiovascular research. 113(13)
Aims Fibroblast growth factor-21 (Fgf21) is an endocrine factor that contributes to many physiological and pathological processes, mainly via its action as a metabolic regulator. Recent studies have shown that Fgf21 plays an important role in cardiac
Autor:
JOAN VENDRELL, BRUNO MARTINEZ-PEREZ, MIRIAM EJARQUE, CRISTINA GUTIERREZ, CATALINA NUÑEZ-ROA, KELLY ROCHE, ROCIO VILA-BEDMAR, MÓNICA BALLESTEROS, IBON REDONDO-ANGULO, ANNA PLANAVILA, FRANCESC VILLARROYA, SONIA FERNÁNDEZ-VELEDO, ANA MEGÍA
Publikováno v:
Translational Research
Repositori Institucional de la Universitat Rovira i Virgili
Consejo Superior de Investigaciones Científicas (CSIC)
Repositori Institucional de la Universitat Rovira i Virgili
Consejo Superior de Investigaciones Científicas (CSIC)
DOI: 10.1016/j.trsl.2016.06.012 URL: http://www.sciencedirect.com/science/article/pii/S1931524416301050 Filiació URV: SI Inclòs a la memòria: SI Angiopoietin-like protein 8 (ANGPTL8), a protein implicated in lipid and glucose homeostasis, is prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3e87c6e84da30a2ccc39458629142d4e
http://hdl.handle.net/20.500.11797/PC1889
http://hdl.handle.net/20.500.11797/PC1889
Publikováno v:
Frontiers in Endocrinology, Vol 6 (2015)
Dipòsit Digital de la UB
Universidad de Barcelona
Frontiers in Endocrinology
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Frontiers in Endocrinology
Recercat. Dipósit de la Recerca de Catalunya
instname
The heart is not traditionally considered either a target or a site of fibroblast growth factor-21 (FGF21) production. However, recent findings indicate that FGF21 can act as a cardiomyokine; that is, it is produced by cardiac cells at significant le
Fibroblast growth factor-21 and the beneficial effects of long-chain n-3 polyunsaturated fatty acids
Autor:
Jan Kopecky, Ibon Redondo-Angulo, Anna Planavila, Joan Villarroya, Dasa Medrikova, Pavel Flachs, Francesc Villarroya, Marta Giralt
Publikováno v:
Lipids. 49(11)
Long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) in the diet protect against insulin resistance and obesity. Fibroblast growth factor-21 (Fgf21) is a hormonal factor released mainly by the liver that has powerful anti-diabetic effects. Here,